Summary

The Association of Public Health Laboratories (APHL), in cooperation with the US Centers for Disease Control and Prevention (CDC) Division of Viral Hepatitis (DVH), is seeking to award one-time funding for up to twelve state or local public health laboratories (PHLs) for the purpose of establishing and/or enhancing capacity to implement the CDC recommended two-step HCV Diagnostic Testing Algorithm for the diagnosis of current HCV infection within a PHL. Funding will be awarded via a contract with APHL.

Eligibility

All state or local US public health laboratories are eligible to apply for the one-time funding, though priority will be given to public health laboratories who were not awarded a contract for expansion of HCV NAT in 2020. 

Anticipated RFP Schedule

November 2, 2022                         RFP Issued
November 23, 2022                      Required Letter of Intent Due to APHL (see below) *NOTE: THIS DEADLINE HAS BEEN EXTENDED FROM THE ORIGINAL DATE (NOVEMBER 16)
December 9, 2022                         RFP Responses Due
December 23, 2022                       Proposal review completed
January 2-9, 2023                          If needed, follow-up interviews and updated proposals due
January 16, 2023                           Final review completed and awardees selected
February 1, 2023                           Estimated contract start date

APHL will communicate any modification to this anticipated schedule on APHL's procurement website (www.aphl.org/rfp) and via an email blast to the public health laboratories.

Response Submittal

Confirmation of Intent to Respond

To allow for appropriate review process planning, a letter of intent is required for consideration. APHL requires that prospective applicants submit a brief email statement indicating an intent to submit a proposal to sarah.buss@aphl.org with a copy to erin.estes@aphl.org. APHL has extended the deadline to submit a letter of intent. The new deadline by which APHL must receive this email is by no later than 5:00pm EST on November 23, 2022.

Final Response

APHL must receive complete responses by 5:00 pm EST on December 9, 2022. Please see Proposal-Required Submissions section for items that must be included in the completed proposal. Applicants may send proposals via email to sarah.buss@aphl.org with a copy to erin.estes@aphl.org.

APHL will send an email acknowledging the receipt of your application; if you do not receive an acknowledgement within 48 hours, please email the RFP point of contact above to confirm receipt.

Materials​

The official RFP document will provide detailed information in regards to this request, please read it in its entirety.

Questions and Answers

Is current HCV testing capability a requirement for this grant?

Would this grant consider a laboratory that doesn't currently have HCV capability, but has the capacity to implement testing under CLIA or research?

When a lab is awarded an APHL contract, do the funds go to the laboratory or does APHL make purchases on the laboratories behalf?

What is the anticipated average award amount?

What type of expenditures would the laboratory be expected to make with the awards?

In Proposal Question #5, are you looking for only measurable objectives that can be completed within the term of the project (2/1 – 6/30/23) or are you also looking for objectives/goals upon the term of the project?